• OPEN AN ACCOUNT
Indian Indices
Sensex
84,031.69 648.98
( 0.78%)
Global Indices
Nasdaq
49,457.25 286.61
(0.58%)
Dow Jones
6,963.84 16.24
(0.23%)
Hang Seng
53,810.56 -530.67
(-0.98%)
Nikkei 225
10,240.27 55.92
(0.55%)
Forex
USD-INR
90.25 0.00
(0.00%)
EUR-INR
105.11 -0.09
(-0.08%)
GBP-INR
121.30 -0.13
(-0.11%)
JPY-INR
0.57 0.00
(0.08%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
344.5797109
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
113.21
8661.01
EPS(TTM)
Face Value()
Div & Yield %
8.3
10
0.43
 

hemo organic ltd
Avadh Sugar & Energy appoints Agha Asif Beig as COO
Nov 26,2025

He joins the company in full-time employment.

Beig holds an M.Sc. (Agri) in Entomology and brings over 30 years of experience in managing integrated sugar and distillery units.

The company confirmed that the appointment does not involve any inter-se relationships with existing directors.

Avadh Sugar & Energy is primarily engaged in the manufacture and sale of sugar and its by-products (molasses, bagasse and press-mud), spirits (including ethanol) and power. The Company has operations in India.

The company reported standalone net loss of Rs 6.59 crore Q2 FY26 as against net profit of Rs 0.83 crore in Q2 FY25. Revenue from operations jumped 5.7% to Rs 668.15 crore in Q2 FY25.

Shares of Avadh Sugar & Energy shed 0.51% to Rs 380 on the BSE.